Shares of Aurora Cannabis Inc. ACB slipped 2.43% to $4.41 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP falling 2.04% ...

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good investment right now? Aurora Cannabis produces and sells a variety of ...

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, ...

For Aurora Cannabis, the 200-day moving average sits at $4.88, according to Benzinga Pro, which is above the current price of $4.79. For more on charts and trend lines, see a description here.

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates ...

This means that Aurora Cannabis Inc. is outperforming the sector as a whole this year. One other Medical stock that has outperformed the sector so far this year is AdaptHealth Corp. (AHCO).

Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...

Insider asked nine CEOs of some of the largest publicly traded cannabis firms — like Curaleaf, Aurora Cannabis, and Weedmaps — for their best predictions ... to major stock exchanges and ...

Shares of Aurora Cannabis Inc. ACB slipped 1.09% to $4.52 Tuesday, on what proved to be an all-around positive trading ...